Skip to main content
Livermore
Livermore
ZHEN

Cerity Partners LLC

SEC CIK
0001566475
Latest filing
Aug 14, 2026

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by Cerity Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings

Shares (Q2 2026)
330,290
Value
$687.0K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ALLO by Cerity Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026330,290$687.0K<0.1%+173,055+110.1%AddedHolders
Q1 2026157,235$383.7K<0.1%+59,326+60.6%AddedHolders
Q4 202597,909$134.1K<0.1%−368,823−79.0%ReducedHolders
Q3 2025466,732$578.7K<0.1%+66,465+16.6%AddedHolders
Q2 2025400,267$452.3K<0.1%+19,843+5.2%AddedHolders
Q1 2025380,424$555.4K<0.1%−6,963−1.8%ReducedHolders
Q4 2024387,387$831.6K<0.1%−44,995−10.4%ReducedHolders
Q3 2024432,382$1.21M<0.1%+232+0.1%AddedHolders
Q2 2024432,150$1.01M<0.1%+7,981+1.9%AddedHolders
Q1 2024424,169$1.90M<0.1%−93,412−18.0%ReducedHolders
Q4 2023517,581$1.66M<0.1%+517,581NewHolders
Q3 20230$00.0%−598,100−100.0%Sold outHolders
Q2 2023598,100$2.97M<0.1%−1,954−0.3%ReducedHolders
Q1 2023600,054$2.96M<0.1%+10,800+1.8%AddedHolders
Q4 2022589,254$3.71M<0.1%−41,171−6.5%ReducedHolders
Q3 2022630,425$6.81M0.1%+29,411+4.9%AddedHolders
Q2 2022601,014$6.85M0.1%−100,039−14.3%ReducedHolders
Q1 2022701,053$6.39M0.1%−2,333−0.3%ReducedHolders
Q4 2021703,386$10.5M0.2%+305,334+76.7%AddedHolders
Q3 2021398,052$10.2M0.2%−2,100−0.5%ReducedHolders
Q2 2021400,152$10.4M0.2%−1,450−0.4%ReducedHolders
Q1 2021401,602$14.2M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.